Microphthalmia is a condition in which one or both eyes are abnormally small, present at birth. A normal adult eye measures about 23.8 mm from front to back, while a microphthalmic eye typically measures less than 21 mm. The condition affects roughly 1 to 3 out of every 10,000 live births, making it one of the most common major eye defects.
The effects range widely. Some people have mildly small eyes with usable vision, while others have severely underdeveloped eyes with little or no sight. Beyond vision itself, a small eye can affect the growth of the eye socket and surrounding facial bones, especially in infants and young children whose skulls are still developing.
Simple vs. Complex Microphthalmia
Doctors classify microphthalmia into two main categories based on whether the eye’s internal structures are affected. In simple microphthalmia, the eye is small but structurally normal on the inside. It may still produce some useful vision, though significant farsightedness is common because the shortened eyeball changes how light focuses on the retina. When the eye is extremely small (under 18 mm) with severe farsightedness, the condition is sometimes called nanophthalmia.
Complex microphthalmia means the small eye also has structural abnormalities in the front or back portions of the eye. These can include a gap in part of the eye’s tissue (coloboma), an underdeveloped lens, or other internal malformations. Complex forms generally carry a worse visual prognosis because the eye’s light-processing structures didn’t form correctly during development.
Microphthalmia can also affect one eye or both. Unilateral cases, where only one eye is involved, leave the other eye to develop normally and carry vision. Bilateral cases present a greater challenge because both eyes are compromised.
What Causes It
The eye begins forming very early in pregnancy, during the first few weeks after conception. Microphthalmia results when something disrupts this process, and the causes fall into two broad groups: genetic mutations and environmental exposures.
Genetic Causes
More than 20 genes have been linked to microphthalmia, all involved in directing how the eye builds itself during embryonic development. The most significant is a gene called SOX2, located on chromosome 3. Mutations in SOX2 account for the largest share of single-gene cases and most often result in both eyes being severely affected or absent entirely. Another gene, OTX2, is responsible for about 3% of bilateral cases and can produce a wide spectrum of severity, from mildly small eyes to completely absent ones.
A third gene, PAX6, plays a central role in both eye and brain development. While PAX6 mutations aren’t a major standalone cause, researchers believe it may work together with SOX2 during a critical step in development: the formation of the lens. If that process fails, the rest of the eye can’t develop properly. In many cases, though, genetic testing doesn’t identify a specific mutation, suggesting there are still undiscovered genetic contributors.
Environmental Causes
Certain prenatal exposures can also interfere with eye formation. Known environmental triggers include alcohol use during pregnancy, vitamin A deficiency, and specific medications such as thalidomide and hydantoin (an anti-seizure drug). Infections passed from mother to fetus, particularly the group known as TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes simplex), have also been implicated.
Associated Conditions and Syndromes
Microphthalmia sometimes occurs on its own, but it frequently appears alongside other birth defects. One large study of over 6 million births found that many infants with microphthalmia had at least one additional anomaly elsewhere in the body.
One of the most well-known associated conditions is CHARGE syndrome, a disorder affecting multiple organ systems. The name is an abbreviation for its hallmark features: coloboma (a gap in eye tissue), heart defects, choanal atresia (blocked nasal passages), growth retardation, genital abnormalities, and ear abnormalities. Children with CHARGE syndrome often have cranial nerve problems that cause swallowing difficulties, facial paralysis, reduced or absent sense of smell, and hearing loss ranging from mild to profound. Cognitive abilities vary widely, from normal intelligence to significant learning disabilities. Microphthalmia can be part of this broader picture.
Other syndromes associated with microphthalmia include Lenz microphthalmia syndrome, which involves skeletal and urinary tract abnormalities, and several chromosomal conditions. When microphthalmia is detected, doctors typically evaluate for these associated problems.
How It’s Diagnosed
Microphthalmia can be detected before birth or identified at delivery. Prenatal screening with ultrasound can raise suspicion as early as 22 weeks of gestation, when the fetal eye structures become visible. However, ultrasound accuracy depends on the baby’s position, movement, and the amount of amniotic fluid present.
When ultrasound findings are concerning, fetal MRI is used to confirm the diagnosis. MRI provides more detailed images of the eye structures and isn’t affected by fetal position or gestational age. It’s considered safe during the second and third trimesters and gives families and doctors clearer information to plan next steps.
After birth, a clinical exam measures the corneal diameter (less than 10 mm in microphthalmia, compared to about 10.5 mm in a typical newborn) and the overall eye length. Imaging with ultrasound or MRI can confirm the axial length measurement and reveal any internal structural problems that distinguish simple from complex forms.
Treatment and Management
There’s no way to make a microphthalmic eye grow to normal size, so treatment focuses on two goals: maximizing whatever vision exists and supporting normal development of the eye socket and face.
Socket Expansion in Infants
A growing child’s eye socket needs an eye (or something eye-sized) inside it to expand properly. When the eye is too small to fill the socket, the bones around it can underdevelop, leading to facial asymmetry. To prevent this, doctors begin fitting clear plastic devices called conformers within the first months of life. These act like placeholders, gently stretching the socket and eyelids.
Conformers need to be upsized regularly, typically every six to eight weeks, as the socket gradually expands. At each visit, the fit is checked and a slightly larger conformer replaces the previous one. The process continues through early childhood, and parents are monitored for signs of problems like the conformer slipping out, irritation, or discomfort.
For more severely small eyes, surgeons may place a self-expanding hydrogel implant inside the eye socket. These implants slowly absorb fluid from surrounding tissue and swell over time, progressively stretching the socket from within. One surgical approach involves placing the implant deep in the socket behind the small eye. Studies following children for 36 months after this procedure have shown excellent bone and eyelid growth.
Prosthetic Eyes
Once the socket is large enough, a custom-painted prosthetic eye can be fitted over the small eye or conformer. This provides a cosmetic match with the other side. Prosthetics need to be remade periodically during childhood as the face grows, and adults typically replace theirs every several years.
Vision Support
When a microphthalmic eye retains some functional vision, particularly in simple microphthalmia, corrective lenses can help address the significant farsightedness that comes with a shorter eye. If only one eye is affected, the healthy eye usually becomes the dominant eye for vision. In bilateral cases with limited sight, early referral to low-vision specialists and developmental support services helps children build communication and mobility skills during critical learning years.
What Affects the Outlook
The visual prognosis depends heavily on the type and severity. A mildly small eye with normal internal anatomy (simple microphthalmia) may achieve functional, correctable vision. A severely small eye with structural malformations inside (complex microphthalmia) is unlikely to provide useful sight.
The cosmetic and structural outcomes, on the other hand, have improved significantly with early intervention. Starting socket expansion in infancy, before the bones of the face harden, gives the best chance of symmetric facial development. Children who begin conformer or expander treatment early and maintain their follow-up schedule consistently tend to have better socket volume and more natural-looking results by the time they reach school age.